Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When MarketBeat Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On ...
Upstream Bio has become the latest ... the initial public offering (IPO) queue amid a flurry of IPO activity in the sector, with three biotechs listing on the Nasdaq last week – Bicara ...
Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report ... and chronic obstructive pulmonary disease. Receive News & Ratings for Upstream Bio Daily - Enter your email address below to ...
Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report)’s stock ... In other Upstream Bio news, major shareholder Ai Upstream Llc acquired 1,175,000 shares of the business’s stock in a transaction ...
Hosted on MSN4mon
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOsThe IPO, which was expanded and the ... according to the company’s filings. Shares of Upstream Bio, Camp4 and CeriBell are trading on the Nasdaq Global Market under the symbols UPB, CAMP and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback